ARGX argenx SE
- 374.630
- -7.920-2.07%
- 374.630
- 0.0000.00%
argenx SE News
Argenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript
Argenx Price Target Cut to $448.00/Share From $451.00 by HC Wainwright & Co.
Argenx Price Target Cut to $448.00/Share From $451.00 by HC Wainwright & Co.
Argenx Is Maintained at Buy by HC Wainwright & Co.
Argenx Is Maintained at Buy by HC Wainwright & Co.
Breaking Down Argenx: 12 Analysts Share Their Views
In the latest quarter, 12 analysts provided ratings for argenx (NASDAQ:ARGX), showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of their recent ratings, show
Argenx Is Maintained at Market Outperform by JMP Securities
Argenx Is Maintained at Market Outperform by JMP Securities
JMP Securities Maintains Market Outperform on Argenx, Lowers Price Target to $468
JMP Securities analyst Jason Butler maintains argenx (NASDAQ:ARGX) with a Market Outperform and lowers the price target from $471 to $468.
Argenx Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 24.82% JMP Securities $471 → $468 Maintains Market Outperform 04/18/2024 38.95% Wedbush → $521
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%
European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.60 to 1,414.50 on the S&P Europe Select ADR Index. With the gain, the index is poi
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT) and Argenx Se (ARGX)
Buy Rating for Argenx Se Backed by Strong VYVGART Sales and Promising Pipeline Prospects
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
European equities traded in the US as American depositary receipts rose late Thursday morning, gaining 0.35% to 1,403.4 on the S&P Europe Select ADR Index. From continental Europe, the gainers were le
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Fading Rate Cut Hopes
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.06% and the actively traded Invesco QQQ Trust (QQQ) was 0.1% lower in Thursday's premarket activity, as traders' hopes of
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of AppLovin Corporation (NASDAQ:APP) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.The company posted revenue of $1.
argenx SE | 6-K: Report of foreign private issuer (related to financial reporting)
Argenx Shares Are Trading Lower Following a Q1 Revenue Miss.
Argenx Shares Are Trading Lower Following a Q1 Revenue Miss.
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday.Shares of Exact Sciences Corporation (NASDAQ:EXAS) fell sharply in today's pre-market trading aft
Argenx Q1 Loss Widens, Total Operating Income Rises
argenx SE (ARGX) reported a Q1 loss Thursday of $1.04 per share, wider than the loss of $0.52 per share a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.70 per share. Total operat
Argenx (ARGX.US): The 2024 Q1 financial report achieved revenue of US$398.3 million, with a previous value of US$218 million, with an expected value of US$405.7 million; earnings per share were -1.04 US dollars, previous value was -0.52 US dollars, and ex
Argenx (ARGX.US): The 2024 Q1 financial report achieved revenue of US$398.3 million, with a previous value of US$218 million, with an expected value of US$405.7 million; earnings per share were -1.04 US dollars, previous value was -0.52 US dollars, and expected value was -0.76 US dollars.
For 2024 Argenx Expects Combined Research And Development And Selling, General And Administrative Expenses To Be Less Than $2B
FINANCIAL GUIDANCEBased on its current operating plans, argenx expects its combined Research and development and Selling, general and administrative expenses in 2024 to be less than $2 billion. argenx
Argenx Q1 2024 GAAP EPS $(0.52) Beats $(0.74) Estimate, Sales $398.283M Miss $405.776M Estimate
argenx (NASDAQ:ARGX) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.74) by 29.73 percent. This is a 50 percent increase over losses of $(1.04) per shar
Analysis
Price Target
No Data
